Pharmafile Logo
Pharmafocus logo
Advanced Search

Health Information appoints Nigel Brooksby as its deputy chairman

February 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information

Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …

Appointment
Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012
Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …

News
Tyverb picture

GSK pulls Tyverb extension in Europe

February 17, 2012
Sales and Marketing GSK, Herceptin, Tyverb, Xeloda

GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …

News
UCB image

UCB releases ‘Epilepsy In Our Time’ video diaries

February 17, 2012
Medical Communications UCB, epilepsy

UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …

News

Life tops up its team with two new appointments

February 17, 2012
Medical Communications Life healthcare communications

 Life Healthcare Communications has made two new appointments, growing its client service and production departments. Matt Leeming joins Life as …

News
Tarceva image

NICE no for first line Tarceva

February 17, 2012
Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva

NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …

News
Merck image

Merck unveils Brazilian joint venture

February 17, 2012
Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets

Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …

News

Cimzia results excite UCB in psoriatic arthritis

February 16, 2012
Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis

UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …

News

Words – the most powerful drug

February 16, 2012
Medical Communications

 Why good internal communication within organisations is essential in these fraught timesBy William Hind, Founder – AlpharmaximThe precise quote by …

Feature
Thought Leadership

Panu Miettinen appointed chief financial officer of Biotie

February 16, 2012
Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies.  He will become a member of the Group’s …

Appointment
lucverhelst

EMA appoints new head of information and communications technology

February 16, 2012
Business Services, Medical Communications, Sales and Marketing EMA, Luc Verhelst

Luc Verhelst has been appointed as the new head of the European Medicines Agency’s information and communications technology unit. Verhelst …

Appointment

MRN launches online training portal

February 16, 2012
Research and Development

16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …

News
Press release

NICE frowns on Botox for headache prevention

February 16, 2012
Sales and Marketing Allergan, Botox, EMA, NHS, NICE

NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug.  …

News

Amgen appoints Michael Severino as senior vice president, Global Development and Corporate chief medical officer

February 16, 2012
Business Services, Research and Development, Sales and Marketing

Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …

Appointment
Teva image

Teva launches generic Aricept in the UK

February 16, 2012
Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva

Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK.  …

News

Emerging markets no haven from HTA, says NICE

February 15, 2012
Andrew Witty, GSK, NICE, NICE International

The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …

News

Most patients happy with hospital care

February 15, 2012
Sales and Marketing NHS, hospital, patient survey

A new survey has found that the vast majority of NHS patients receiving outpatient hospital care are happy with the …

News
Pfizer picture

FDA accepts Pfizer rare disease drug for review

February 15, 2012
Sales and Marketing EMA, FDA, FoldRx, Pfizer, tafamidis meglumine

The FDA has accepted for review Pfizer’s new drug to treat a rare neurodegenerative disease. Pfizer is seeking a licence …

News
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Feature

Strategic North appoints Paula Lashley as consultant

February 15, 2012
Business Services, Medical Communications, Sales and Marketing

Healthcare strategic marketing consultancy Strategic North, who recently reached the final of the Manchester Evening News Business of the Year …

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026